ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 7

Influence of TNF on Anti-Inflammatory Tyrosine-Hydroxylase-Positive Synovial Cells in Rheumatoid Arthritis and Osteoarthritis

Zsuzsa Jenei-Lanzl, Markus Herrmann and Rainer Straub, Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine, University Hospital Regensburg, Regensburg, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Catecholamines, Rheumatoid arthritis (RA), synovium and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

In recent studies we demonstrated that catecholamines produced by tyrosine-hydroxylase-positive (TH+) synovial cells are able to mediate anti-inflammatory effects in rheumatoid arthritis (RA).a TNF has been shown to be toxic to catecholaminergic neurons in Parkinson´s disease (PD).b Therefore, the aim of this study was to analyze whether TNF exhibits also inhibitory effects on TH in the chronic inflamed synovium.

Methods:

Human mixed synovial cells were isolated from RA and osteoarthritis (OA) patients and “induced TH+ cells” (iTH+) were generated from human mesenchymal stem cells (MSC) as described previously.a Cells were cultivated under hypoxia (1% O2), because the microenvironment of inflamed joints is hypoxic. TNF and the anti-TNF etanercept were administered in different concentrations and combinations. Expression and activity of TH was analyzed by immunofluorescence and TH activity assay. In addition, catecholamines were quantified via HPLC and the quality of catecholaminergic differentiation was investigated staining VMAT2, Nurr1, and βIII tubulin as markers.

Results:

In mixed synovial cell culture, TNF inhibited TH activity and catecholamine synthesis compared to untreated control in both OA and RA. In general, TNF did not disturb catecholaminergic differentiation of MSCs to iTH+ cells. However, TH staining of TNF-treated iTH+ cells was weaker, the TH activity and the amount of produced catecholamines lower. Similarly, expression of VMAT2, Nurr1, and βIII tubulin decreased after TNF-treatment in iTH+ cells. The effects of TNF were reversed by etanercept in both synovial cell and iTH+ cell cultures.

Conclusion:

This study shows TNF inhibition of TH expression and activity in TH+ synovial cells and differentiating iTH+ cells leading to the decrease of anti-inflammatory acting catecholamines. This might be a reason why resident synovial TH+ cells are not able to unfold their anti-inflammatory effects in RA.


Disclosure: Z. Jenei-Lanzl, None; M. Herrmann, None; R. Straub, None.

To cite this abstract in AMA style:

Jenei-Lanzl Z, Herrmann M, Straub R. Influence of TNF on Anti-Inflammatory Tyrosine-Hydroxylase-Positive Synovial Cells in Rheumatoid Arthritis and Osteoarthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/influence-of-tnf-on-anti-inflammatory-tyrosine-hydroxylase-positive-synovial-cells-in-rheumatoid-arthritis-and-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influence-of-tnf-on-anti-inflammatory-tyrosine-hydroxylase-positive-synovial-cells-in-rheumatoid-arthritis-and-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology